Please login to the form below

Not currently logged in
Email:
Password:

opioid overdose

This page shows the latest opioid overdose news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

FDA panel backs Pfizer and Teva abuse-resistant painkillers

In the case of Troxyca ER, the inclusion of opioid blocker naltrexone is designed to achieve the same end result. ... Opioid prescribing continues to fuel the epidemic as at least half of all opioid overdose deaths in the country involve a prescription

Latest news

  • FDA approves Adapt Pharma's opioid overdose nasal spray FDA approves Adapt Pharma's opioid overdose nasal spray

    FDA approves Adapt Pharma's opioid overdose nasal spray. Narcan aims to curb rise in deaths from opioid abuse. ... The FDA has approved Adapt Pharma's Narcan nasal spray to reverse the effects of an opioid overdose.

  • Purdue gets FDA nod for abuse-deterrent painkiller Purdue gets FDA nod for abuse-deterrent painkiller

    According to figures from the Centers for Disease Control and Prevention (CDC), every day in the US 105 people die as a result of drug overdose with opioid analgesics killing more ... which combines oxycodone with naloxone to help limit the effects of

  • FDA approves pain drug that has reduced risk of abuse FDA approves pain drug that has reduced risk of abuse

    The US FDA has approved a new opioid-based pain treatment that is intended to reduce the risk of abuse by people who use the drug for non-medical reasons. ... Targiniq ER, a combination of oxycodone hydrochloride and naloxone hydrochloride, is now

  • FDA backs heroin overdose treatment FDA backs heroin overdose treatment

    contact with someone at risk of an opioid overdose. ... FDA commissioner Margaret Hamburg commented that the device was “ an important new tool in our arsenal to more effectively combat the devastating effects of opioid overdose, which is one part of

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • "Legal highs" ruling leaves illegal labs laughing

    So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.

  • "Legal highs" ruling leaves illegal labs laughing

    So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics